| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/27/2004 | WO2004044185A1 Recombinant vitellogenin enriched feed |
| 05/27/2004 | WO2004044182A2 Highly permissive cell lines for hepatitis c virus replication |
| 05/27/2004 | WO2004044176A2 Adenoviral vector vaccine |
| 05/27/2004 | WO2004044175A2 Fluorescence guided cell capture |
| 05/27/2004 | WO2004044172A2 A method for purifying and recovering silk proteins in soluble form and uses thereof |
| 05/27/2004 | WO2004044170A2 A pancreatic islet transcription factor and uses thereof |
| 05/27/2004 | WO2004044168A2 Genetically encoded fluorescent reporters of kinase, methyltransferase, and acetyl-transferase activities |
| 05/27/2004 | WO2004044167A2 Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide |
| 05/27/2004 | WO2004044166A2 Carbohydrate-associated proteins |
| 05/27/2004 | WO2004044165A2 Lipid-associated proteins |
| 05/27/2004 | WO2004044164A2 Method for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | WO2004044163A2 Methods for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | WO2004044162A2 HUMAN ACID-SENSING ION CHANNEL 2b (hASIC2b) |
| 05/27/2004 | WO2004044160A2 Muc1 interference rna compositions and methods derived therefrom |
| 05/27/2004 | WO2004044159A2 Receptors and membrane-associated proteins |
| 05/27/2004 | WO2004044152A2 A novel pth responsive gene |
| 05/27/2004 | WO2004044147A2 Modified dendritic cells |
| 05/27/2004 | WO2004044145A2 Compositions and methods for enhancing disease resistance in fish |
| 05/27/2004 | WO2004044126A2 Novel proteins and their uses |
| 05/27/2004 | WO2004044125A2 Vesicle-associated proteins |
| 05/27/2004 | WO2004044011A2 Combinatorial libraries of monomer domains |
| 05/27/2004 | WO2004044007A1 Production of ubiquitin fusion proteins |
| 05/27/2004 | WO2004044006A1 Conjugates of interleukin-10 and polymers |
| 05/27/2004 | WO2004044005A1 Kit for assaying human low-molecular weight cd14 and antibody |
| 05/27/2004 | WO2004044004A2 T cell receptor display |
| 05/27/2004 | WO2004044003A2 Use of edg2 receptor in an animal model of heart failure |
| 05/27/2004 | WO2004044002A1 Growth hormone variations in humans and its uses |
| 05/27/2004 | WO2004044001A2 Acetylated hmgb1 protein |
| 05/27/2004 | WO2004044000A2 Compounds and methods for modulating functions of classical cadherins |
| 05/27/2004 | WO2004043999A2 Hsan ii related gene and expression products and uses thereof |
| 05/27/2004 | WO2004043998A1 Therapeutic modulation of chemokines using a helminth parasite chemokine-binding protein |
| 05/27/2004 | WO2004043997A2 Chimeric autoprocessing polypeptides and uses thereof |
| 05/27/2004 | WO2004043995A2 Process for the preparation of glatiramer acetate by polymerisation of n-carboxy anhydrides of l-alanine, l-tyrosine, benzyl l-glutamate and benzyloxycarbonyl l-lysine |
| 05/27/2004 | WO2004043988A2 Ptprk immunogenic peptide |
| 05/27/2004 | WO2004043886A2 Production of pharmaceutically active proteins in sprouted seedlings |
| 05/27/2004 | WO2004043563A2 Methods of isolation of active compounds and activated targets |
| 05/27/2004 | WO2004043488A1 Malaria vaccine |
| 05/27/2004 | WO2004043468A1 Screening method |
| 05/27/2004 | WO2004043407A2 Methods and products for treating staphylococcal infections |
| 05/27/2004 | WO2004043404A2 Process for designing inhibitors of influenza virus non-structural protein 1 |
| 05/27/2004 | WO2004043403A2 Synthetic single domain polypeptides mimicking apolipoprotein e and methods of use |
| 05/27/2004 | WO2004043399A2 Methods and compositions for inducing immune responses and protective immunity by priming with alphavirus replicon vaccines |
| 05/27/2004 | WO2004043397A2 Compositions and methods for the treatment of rheumatoid arthritis |
| 05/27/2004 | WO2004043383A2 A new target for angiogenesis and anti-angiogenesis therapy |
| 05/27/2004 | WO2004043382A2 Enhanced variants of erythropoietin and methods of use |
| 05/27/2004 | WO2004043376A2 Compositions and methods for treating or preventing pneumococcal infection |
| 05/27/2004 | WO2004043361A2 Compositions and methods for the treatment of natural killer cell related diseases |
| 05/27/2004 | WO2004043347A2 Calcitonin drug-oligomer conjugates, and uses thereof |
| 05/27/2004 | WO2004043340A2 Alpha 5 beta 1 and its ability to regulate the cell survival pathway |
| 05/27/2004 | WO2004043332A2 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
| 05/27/2004 | WO2004043287A2 Novel compositions that enhance production performance in avians |
| 05/27/2004 | WO2004043238A2 Biomarkers for intra-amniotic inflammation |
| 05/27/2004 | WO2004043233A2 Assay for autoantibodies to folate receptors |
| 05/27/2004 | WO2004043232A2 Methods for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | WO2004043145A2 Auxin-repressed, dormancy-associated promoter and uses thereof |
| 05/27/2004 | WO2004043141A2 Novel inhibin-related multiple antigenic peptide compositions that enhance production performance in avians |
| 05/27/2004 | WO2004035616A3 Adenovirus expressing genes in reverse order and use thereof |
| 05/27/2004 | WO2004034780A3 Method of producing recombinant proteins in the mammary gland of non-transgenic mammals |
| 05/27/2004 | WO2004033694A3 Promoter to il-18bp, its preparation and use |
| 05/27/2004 | WO2004026893A3 Synthetic chemokines labeled at selected positions |
| 05/27/2004 | WO2004026772A3 Ammonia-oxidizing bacteria and methods of using and detecting the same |
| 05/27/2004 | WO2004024762A3 Il-8 like protein |
| 05/27/2004 | WO2004016653A8 Bactericidal, anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp) or human neutrophil elastase |
| 05/27/2004 | WO2004016274B1 Novel peptide-conjugated oligomeric compounds |
| 05/27/2004 | WO2004009762A3 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 05/27/2004 | WO2004007530A3 Modified proteins stabilized in a desired conformation and methods for producing same |
| 05/27/2004 | WO2004001051A3 Recombinant measles viruses expressing epitopes pf antigens of rna viruses and use of the recombinant viruses for the preparation of vaccine compositions |
| 05/27/2004 | WO2003104276A9 Genes and polypeptides relating to hepatocellular or colorectal carcinoma |
| 05/27/2004 | WO2003099992A3 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins |
| 05/27/2004 | WO2003097842A8 Measure for non-homologous dna recombination process in mammalian cells |
| 05/27/2004 | WO2003089455A3 Low-cost production of peptides |
| 05/27/2004 | WO2003075655A3 Novel vip3 toxins and methods of use |
| 05/27/2004 | WO2003072749A3 Enkurin and uses thereof |
| 05/27/2004 | WO2003068977A3 Fusion constructs containing active sections of tnf ligands |
| 05/27/2004 | WO2003065928A9 Therapeutic polyesters and polyamides |
| 05/27/2004 | WO2003064448A3 Degp protease: cleavage site identification and proteolysis of a natural target in e. coli |
| 05/27/2004 | WO2003061589A3 Methods for treating diseases or conditions with peptide constructs |
| 05/27/2004 | WO2003046567A3 Protein biopolymer markers predictive of alzheimers disease |
| 05/27/2004 | WO2003033658A3 Neutrokine-alpha and neutrokine-alpha splice variant |
| 05/27/2004 | WO2003031623A9 Cocoa flavour precursor peptides |
| 05/27/2004 | WO2003028659A3 Methods and compositions for modulating apoptosis |
| 05/27/2004 | WO2003025177A3 Sequences involved in phenomena of tumour suppression, tumour reversion, adoptosis and/or resistance to viruses and the use thereof as medicaments |
| 05/27/2004 | WO2003019142A9 Compositions and methods for detection and regulation of genes associated with ruptured atherosclerotic plaque |
| 05/27/2004 | WO2003018748A3 Anti-cancer and wound healing compounds |
| 05/27/2004 | WO2003018629A8 Cage antigen |
| 05/27/2004 | WO2003015705A3 In situ immunization |
| 05/27/2004 | WO2003014155A3 Labelled conjugates of p17 protein and their use in aids diagnosis |
| 05/27/2004 | WO2003012053A9 Identification of receptor and heparin binding sites in fgf4 by structure-based mutagenesis |
| 05/27/2004 | WO2003008541A8 Extracellular junctional adhesion molecules |
| 05/27/2004 | WO2003004604A3 Phage displayed pdz domain ligands |
| 05/27/2004 | WO2003002155B1 Vector encoding human globlin gene and use thereof in treatment of hemoglobinopathies |
| 05/27/2004 | WO2003001249A3 Modulating photoreactivity in a cell |
| 05/27/2004 | WO2002097037A8 Melanin-concentrating hormone analogs |
| 05/27/2004 | WO2002095062A3 Serine-threonine phosphatase protein of a parasitic organism of the apicomplexa phylum, applications in therapeutics |
| 05/27/2004 | WO2002092827A3 Corona-virus-like particles comprising functionally deleted genomes |
| 05/27/2004 | WO2002085923A3 In vivo incorporation of unnatural amino acids |
| 05/27/2004 | WO2002081413A3 One dimensional unichemo protection (ucp) in organic synthesis |
| 05/27/2004 | WO2002060480A9 Methods for treating or preventing skin disorders using cd2-binding agents |
| 05/27/2004 | WO2002055721B1 Modular transfection systems based on nucleoprotein filaments |
| 05/27/2004 | WO2002043478A8 Transgenic transchromosomal rodents for making human antibodies |